Evidence map›Paper›PMID 18160100›Full record

ArticleActa histochemica2008

Image analysis of the AgNOR response in ras-transformed human breast epithelial cells.

Maria Luiza S Mello, Benedicto C Vidal, Jose Russo, Wolfgang Planding, Ulrich Schenck

Open access · greenAbstract read
In one paragraph

Article in Acta histochemica, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Maria Luiza S MelloDepartment of Cell Biology, Institute of Biology, State University of Campinas (UNICAMP), 13083-863 Campinas, Brazil. mlsmello@unicamp.br
Benedicto C Vidal
Jose Russo
Wolfgang Planding
Ulrich Schenck
Technical University of Munich · DEFox Chase Cancer Center · USUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

MOLECULAR BASIS OF BREAST CELL TRANSFORMATIONR01CA067238 · NCI · FOX CHASE CANCER CENTER · PI RUSSO, JOSE · 1995 to 2000
$48k
NCI NIH HHS R01 CA067238NCI NIH HHS R01 CA67238
6 · The paper itself

Abstract

The argyrophylic staining of the nucleolar organizer regions (AgNOR positive response) in interphase nuclei is often related directly to the cellular demand for ribosome biogenesis and is considered of relevance in studies of tumor pathology. Transformation of human breast epithelial MCF-10A cells by the c-Ha-ras oncogene results in altered growth, invasiveness and tumorigenicity in nude mice. Since ras transformation may be associated with a more intense nucleolar activity, we examined the influence of transfection by the Ha-ras oncogene on AgNOR staining response in MCF-10A cells. Following assessment of the AgNOR response with video image analysis, the AgNOR-positive areas and the AgNOR area/nuclear area ratio, but not the number of AgNOR aggregates or dots per nucleus, were found to be much higher after ras transformation. A role of the Ha-ras transformation on the nucleolar activity of the MCF-10A is thus suggested as assessed by the AgNOR staining. Based on data in the literature, it is also hypothesized that a decreased wild-type p53 level, possibly promoted by the ras transformation, may be associated with the increased AgNOR response.

Indexed as

Cell Transformation, NeoplasticAnimalsAntigens, NuclearBreastBreast NeoplasmsCell Line, TransformedCell NucleolusEpithelial CellsGenes, rasHumansImage Processing, Computer-AssistedMiceMicrospectrophotometryModels, BiologicalTransfectionAntigens, Nuclearnucleolar organizer region associated proteins

Identifiers

PMID18160100
PMCPMC2517175
OpenAlexW1987469768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.